211 related articles for article (PubMed ID: 36099043)
41. Partial remission in ankylosing spondylitis and non-radiographic axial spondyloarthritis in treatment with infliximab plus naproxen or naproxen alone: associations between partial remission and baseline disease characteristics.
Sieper J; Rudwaleit M; Lenaerts J; Wollenhaupt J; Myasoutova L; Park SH; Song YW; Yao R; Huyck S; Govoni M; Chitkara D; Vastesaeger N
Rheumatology (Oxford); 2016 Nov; 55(11):1946-1953. PubMed ID: 27411482
[TBL] [Abstract][Full Text] [Related]
42. Predictors of remission in people with axial spondyloarthritis: A systematic literature review.
Pinto AS; Farisogullari B; Machado PM
Semin Arthritis Rheum; 2022 Oct; 56():152078. PubMed ID: 35944350
[TBL] [Abstract][Full Text] [Related]
43. Effects of Long-Term Etanercept Treatment on Clinical Outcomes and Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis: 104-Week Results From a Randomized, Placebo-Controlled Study.
Dougados M; van der Heijde D; Sieper J; Braun J; Citera G; Lenaerts J; van den Bosch F; Wei JC; Pedersen R; Bonin R; Jones H; Marshall L; Logeart I; Vlahos B; Bukowski JF; Maksymowych WP
Arthritis Care Res (Hoboken); 2017 Oct; 69(10):1590-1598. PubMed ID: 28482137
[TBL] [Abstract][Full Text] [Related]
44. Effect of biologic disease-modifying anti-rheumatic drugs targeting remission in axial spondyloarthritis: systematic review and meta-analysis.
Cruz-Machado AR; Rodrigues-Manica S; Silva JL; Alho I; Coelho C; Duarte J; Florêncio C; Pimentel-Santos FM; Tavares-Costa J; Vieira-Sousa E
Rheumatology (Oxford); 2020 Nov; 59(11):3158-3171. PubMed ID: 32696064
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of active inflammation, chronic structural damage, and response to treatment of sacroiliitis in axial spondyloarthritis using the Spondyloarthritis research consortium of Canada scoring system.
Zhang Y; Guo Z; Zhan Y; Qu J; Lei X
BMC Musculoskelet Disord; 2022 Jul; 23(1):654. PubMed ID: 35804360
[TBL] [Abstract][Full Text] [Related]
46. Non-radiographic axial spondyloarthritis in Tunisia: main characteristics and detailed comparison with ankylosing spondylitis.
Ben Abdelghani K; Gzam Y; Fazaa A; Miladi S; Sellami M; Souabni L; Kassab S; Chekili S; Zakraoui L; Laater A
Clin Rheumatol; 2021 Apr; 40(4):1361-1367. PubMed ID: 32974836
[TBL] [Abstract][Full Text] [Related]
47. Efficacy of TNF-α Inhibitors in the Treatment of nr-axSpA: A Systematic Review and Meta-Analysis Based on Randomized Controlled Trials.
Shentu H; Sha S; He Y; He M; Dong N; Huang Z; Lai H; Chen M; Huang J; Huang X
Int Arch Allergy Immunol; 2024; 185(6):590-599. PubMed ID: 38432201
[TBL] [Abstract][Full Text] [Related]
48. Does a short course of etanercept influence disease progression and radiographic changes in patients suspected of non-radiographic axial spondyloarthritis? Three -years follow- up of a placebo-controlled trial.
Rusman T; van der Weijden M; Nurmohamed MT; van Denderen CJ; Landewé R; Bet PM; Bijl CV; van der Laken CJ; van der Horst-Bruinsma IE
Scand J Rheumatol; 2023 Mar; 52(2):137-141. PubMed ID: 35543102
[TBL] [Abstract][Full Text] [Related]
49. ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update.
Ramiro S; Nikiphorou E; Sepriano A; Ortolan A; Webers C; Baraliakos X; Landewé RBM; Van den Bosch FE; Boteva B; Bremander A; Carron P; Ciurea A; van Gaalen FA; Géher P; Gensler L; Hermann J; de Hooge M; Husakova M; Kiltz U; López-Medina C; Machado PM; Marzo-Ortega H; Molto A; Navarro-Compán V; Nissen MJ; Pimentel-Santos FM; Poddubnyy D; Proft F; Rudwaleit M; Telkman M; Zhao SS; Ziade N; van der Heijde D
Ann Rheum Dis; 2023 Jan; 82(1):19-34. PubMed ID: 36270658
[TBL] [Abstract][Full Text] [Related]
50. The frequency of non-radiographic axial spondyloarthritis in relation to symptom duration in patients referred because of chronic back pain: results from the Berlin early spondyloarthritis clinic.
Poddubnyy D; Brandt H; Vahldiek J; Spiller I; Song IH; Rudwaleit M; Sieper J
Ann Rheum Dis; 2012 Dec; 71(12):1998-2001. PubMed ID: 22915622
[TBL] [Abstract][Full Text] [Related]
51. Axial Spondyloarthritis in Japan.
Kameda H; Kishimoto M; Kobayashi S; Tomita T; Morita A; Yamamura M
Curr Rheumatol Rep; 2022 May; 24(5):149-155. PubMed ID: 35380380
[TBL] [Abstract][Full Text] [Related]
52. Treatment overview of axial spondyloarthritis in 2023.
Baraliakos X; Kiltz U; Kononenko I; Ciurea A
Best Pract Res Clin Rheumatol; 2023 Sep; 37(3):101858. PubMed ID: 37673758
[TBL] [Abstract][Full Text] [Related]
53. Therapeutic controversies in spondyloarthritis: nonsteroidal anti-inflammatory drugs.
Poddubnyy D; van der Heijde D
Rheum Dis Clin North Am; 2012 Aug; 38(3):601-11. PubMed ID: 23083758
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of the nonsteroidal anti-inflammatory drug-sparing effect of etanercept in axial spondyloarthritis: results of the multicenter, randomized, double-blind, placebo-controlled SPARSE study.
Dougados M; Wood E; Combe B; Schaeverbeke T; Miceli-Richard C; Berenbaum F; Koppiker N; Dubanchet A; Logeart I
Arthritis Res Ther; 2014 Nov; 16(6):481. PubMed ID: 25428762
[TBL] [Abstract][Full Text] [Related]
55. Treatment With Tumor Necrosis Factor Inhibitors Is Associated With a Time-Shifted Retardation of Radiographic Sacroiliitis Progression in Patients With Axial Spondyloarthritis: 10-Year Results From the German Spondyloarthritis Inception Cohort.
Torgutalp M; Rios Rodriguez V; Proft F; Protopopov M; Verba M; Rademacher J; Haibel H; Sieper J; Rudwaleit M; Poddubnyy D
Arthritis Rheumatol; 2022 Sep; 74(9):1515-1523. PubMed ID: 35437900
[TBL] [Abstract][Full Text] [Related]
56. Is tapering or discontinuation of biologic treatment in patients with radiographic and nonradiographic axial spondyloarthritis reasonable? : A local cohort study.
Harman H; Kaban N
Z Rheumatol; 2024 Feb; 83(Suppl 1):55-61. PubMed ID: 35672504
[TBL] [Abstract][Full Text] [Related]
57. Characteristics of patients with axial spondyloarthritis by geographic regions: PROOF multicountry observational study baseline results.
Poddubnyy D; Sieper J; Akar S; Muñoz-Fernández S; Haibel H; Hojnik M; Ganz F; Inman RD
Rheumatology (Oxford); 2022 Aug; 61(8):3299-3308. PubMed ID: 34897381
[TBL] [Abstract][Full Text] [Related]
58. Elevated faecal calprotectin is linked to worse disease status in axial spondyloarthritis: results from the SPARTAKUS cohort.
Olofsson T; Lindqvist E; Mogard E; Andréasson K; Marsal J; Geijer M; Kristensen LE; Wallman JK
Rheumatology (Oxford); 2019 Jul; 58(7):1176-1187. PubMed ID: 30649509
[TBL] [Abstract][Full Text] [Related]
59. Nonradiographic axial spondyloarthritis: expanding the spectrum of an old disease: A narrative review.
Magrey M; Schwartzman S; de Peyrecave N; Sloan VS; Stark JL
Medicine (Baltimore); 2022 Apr; 101(15):e29063. PubMed ID: 35475794
[TBL] [Abstract][Full Text] [Related]
60. Circulating cell-free DNA correlate to disease activity and treatment response of patients with radiographic axial spondyloarthritis.
Peng Y; Wu Y; Chen S; Liu Y; Qian H; He Y; Huang H; Cai M; Liu W; Shi G
Sci Rep; 2024 Jan; 14(1):178. PubMed ID: 38168507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
